The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Used to treat anemia due to chronic kidney disease (CKD) in patients undergoing dialysis treatment
Global Roxadustat market is projected to reach US$ 18250 million in 2029, increasing from US$ 2350 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Roxadustat market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Roxadustat market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fibro Gen
AstraZeneca
Astellas Pharma Inc.
Salubris
Segment by Type
20mg
50mg
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Roxadustat report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Used to treat anemia due to chronic kidney disease (CKD) in patients undergoing dialysis treatment
Global Roxadustat market is projected to reach US$ 18250 million in 2029, increasing from US$ 2350 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Roxadustat market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Roxadustat market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fibro Gen
AstraZeneca
Astellas Pharma Inc.
Salubris
Segment by Type
20mg
50mg
Segment by Application
Pharmacy
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Roxadustat report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Roxadustat Market Overview
1.1 Product Overview and Scope of Roxadustat
1.2 Roxadustat Segment by Type
1.2.1 Global Roxadustat Market Value Comparison by Type (2023-2029)
1.2.2 20mg
1.2.3 50mg
1.3 Roxadustat Segment by Application
1.3.1 Global Roxadustat Market Value by Application: (2023-2029)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Global Roxadustat Market Size Estimates and Forecasts
1.4.1 Global Roxadustat Revenue 2018-2029
1.4.2 Global Roxadustat Sales 2018-2029
1.4.3 Global Roxadustat Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Roxadustat Market Competition by Manufacturers
2.1 Global Roxadustat Sales Market Share by Manufacturers (2018-2023)
2.2 Global Roxadustat Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Roxadustat Average Price by Manufacturers (2018-2023)
2.4 Global Roxadustat Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Roxadustat, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Roxadustat, Product Type & Application
2.7 Roxadustat Market Competitive Situation and Trends
2.7.1 Roxadustat Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Roxadustat Players Market Share by Revenue
2.7.3 Global Roxadustat Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Roxadustat Retrospective Market Scenario by Region
3.1 Global Roxadustat Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Roxadustat Global Roxadustat Sales by Region: 2018-2029
3.2.1 Global Roxadustat Sales by Region: 2018-2023
3.2.2 Global Roxadustat Sales by Region: 2024-2029
3.3 Global Roxadustat Global Roxadustat Revenue by Region: 2018-2029
3.3.1 Global Roxadustat Revenue by Region: 2018-2023
3.3.2 Global Roxadustat Revenue by Region: 2024-2029
3.4 North America Roxadustat Market Facts & Figures by Country
3.4.1 North America Roxadustat Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Roxadustat Sales by Country (2018-2029)
3.4.3 North America Roxadustat Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Roxadustat Market Facts & Figures by Country
3.5.1 Europe Roxadustat Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Roxadustat Sales by Country (2018-2029)
3.5.3 Europe Roxadustat Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Roxadustat Market Facts & Figures by Country
3.6.1 Asia Pacific Roxadustat Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Roxadustat Sales by Country (2018-2029)
3.6.3 Asia Pacific Roxadustat Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Roxadustat Market Facts & Figures by Country
3.7.1 Latin America Roxadustat Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Roxadustat Sales by Country (2018-2029)
3.7.3 Latin America Roxadustat Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Roxadustat Market Facts & Figures by Country
3.8.1 Middle East and Africa Roxadustat Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Roxadustat Sales by Country (2018-2029)
3.8.3 Middle East and Africa Roxadustat Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Roxadustat Sales by Type (2018-2029)
4.1.1 Global Roxadustat Sales by Type (2018-2023)
4.1.2 Global Roxadustat Sales by Type (2024-2029)
4.1.3 Global Roxadustat Sales Market Share by Type (2018-2029)
4.2 Global Roxadustat Revenue by Type (2018-2029)
4.2.1 Global Roxadustat Revenue by Type (2018-2023)
4.2.2 Global Roxadustat Revenue by Type (2024-2029)
4.2.3 Global Roxadustat Revenue Market Share by Type (2018-2029)
4.3 Global Roxadustat Price by Type (2018-2029)
5 Segment by Application
5.1 Global Roxadustat Sales by Application (2018-2029)
5.1.1 Global Roxadustat Sales by Application (2018-2023)
5.1.2 Global Roxadustat Sales by Application (2024-2029)
5.1.3 Global Roxadustat Sales Market Share by Application (2018-2029)
5.2 Global Roxadustat Revenue by Application (2018-2029)
5.2.1 Global Roxadustat Revenue by Application (2018-2023)
5.2.2 Global Roxadustat Revenue by Application (2024-2029)
5.2.3 Global Roxadustat Revenue Market Share by Application (2018-2029)
5.3 Global Roxadustat Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Fibro Gen
6.1.1 Fibro Gen Corporation Information
6.1.2 Fibro Gen Description and Business Overview
6.1.3 Fibro Gen Roxadustat Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Fibro Gen Roxadustat Product Portfolio
6.1.5 Fibro Gen Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Roxadustat Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Roxadustat Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Astellas Pharma Inc.
6.3.1 Astellas Pharma Inc. Corporation Information
6.3.2 Astellas Pharma Inc. Description and Business Overview
6.3.3 Astellas Pharma Inc. Roxadustat Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Astellas Pharma Inc. Roxadustat Product Portfolio
6.3.5 Astellas Pharma Inc. Recent Developments/Updates
6.4 Salubris
6.4.1 Salubris Corporation Information
6.4.2 Salubris Description and Business Overview
6.4.3 Salubris Roxadustat Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Salubris Roxadustat Product Portfolio
6.4.5 Salubris Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Roxadustat Industry Chain Analysis
7.2 Roxadustat Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Roxadustat Production Mode & Process
7.4 Roxadustat Sales and Marketing
7.4.1 Roxadustat Sales Channels
7.4.2 Roxadustat Distributors
7.5 Roxadustat Customers
8 Roxadustat Market Dynamics
8.1 Roxadustat Industry Trends
8.2 Roxadustat Market Drivers
8.3 Roxadustat Market Challenges
8.4 Roxadustat Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
